Chalfont St. Giles, UK and Waltham, MA USA -- 1 October 2012 -- GE Healthcare Life Sciences, a business unit of GE Healthcare (NYSE: GE) and NetBio, a leading technology provider in the emerging field of rapid DNA analysis, announced today the launch of DNAscan™ Rapid DNA Analysis™ System, a fast, rugged and easy-to-use DNA analysis instrument for forensic applications.
Chalfont St Giles, UK and Waltham, MA USA-- 30 July 2012 -- GE Healthcare Life Sciences, a business unit of GE Healthcare (NYSE: GE) and NetBio, a leading provider of technologies for the emerging field of Rapid DNA Analysis, announced today an alliance to commercialize new, fast, cost effective and easy-to-use DNA sample collection and analysis products for the forensic market.
business unit
tags
- Partnering with GE Healthcare Performance Solutions, Ogden Regional increased efficiency in the operating room through analysis and restructuring of surgical schedules
- Capacity management project resulted in five percent growth in OR utilization in one year and increased procedural volume by 11.6 percent
- New capacity enables Ogden Regional's surgeons to better schedule procedures, patients to more easily book procedures and complete all necessary intake processes
business unit
tags
Chalfont St. Giles, UK, and Shenzhen, China -- 12 June, 2012 -- GE Healthcare, the healthcare business of GE (NYSE: GE), and BGI, the world's largest genomics organization, jointly announced today a pioneering multi-year research collaboration in stem cell science.
business unit
tags
Chalfont St Giles, UK -- 10 May 2012 -- GE Healthcare, the healthcare business of GE (NYSE: GE) announced today that it has completed the acquisition of Xcellerex, Inc., a supplier of innovative manufacturing technologies for the fast-growing biopharmaceutical industry.